Carzenide

Overview

Carzenide (4-Sulfamoylbenzoic acid) is the major circulating metabolite of Mafenide ( HY-B0614 ) in plasma. Carzenide is a strong CAII competitive inhibitor. Carzenide can be used in the research of epilepsy and cervical cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Drug Metabolite | Products > Signaling Pathways > Carbonic Anhydrase

Product Information

• Catalog No.: HY-B0989
• CAS No.: 138-41-0
• Molecular Formula: C7H7NO4S
• Molecular Weight: 201.20
• Purity: 99.45%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (12.43 mM); Clear solution
• Availability: In-stock

Source

Original product source